Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
As a practicing cardiologist at Providence Heart Institute in Portland, Oregon, and the medical director of Providence's Center for Cardiovascular Analytics, Research, and Data Science, Gluckman an brings deep experience in both patient care and health system transformation. The conversation covers remote patient monitoring, digital health tools, and the role of value-based models in promoting optimal therapy.
Articles
Electronic Health Records and Consumer Wearables
Experts highlight that well-integrated electronic health records and wearable devices can enhance diagnostic accuracy and patient engagement in arrhythmia care, while emphasizing the importance of combining technology with comprehensive clinical evaluation to guide efficient, personalized testing.
Prescribed Ambulatory Cardiac Rhythm Monitors
Experts discuss how choosing the right cardiac rhythm monitor involves balancing symptom frequency, patient risk, and device capabilities to ensure efficient, cost-effective, and patient-centered diagnosis while avoiding unnecessary testing.
Best Practices for Diagnosing Arrhythmia
Experts discuss how arrhythmia evaluation is tailored based on symptom frequency, severity, and patient risk, using a stepwise approach from short-term to extended monitoring to guide timely and effective diagnosis and management.
Optimizing the Management of Atrial Fibrillation Through Team-Based Care
Experts discuss how rising arrhythmia burdens and workforce challenges are driving a shift toward team-based care, smarter diagnostics, and artificial intelligence–driven risk stratification to improve outcomes and efficiency.
Unmet Needs in the Management of Atrial Fibrillation
Experts discuss the persistent clinical and systemic challenges in diagnosing and treating atrial fibrillation, emphasizing the need for earlier identification—especially in high-risk, comorbid populations—while highlighting the limitations of current risk models, the complexity of managing atrial fibrillation burden, and the importance of integrating wearable data into precision-based care without overburdening clinicians or compromising clinical relevance.
Common Comorbidities and Underdiagnosis Associated With Atrial Fibrillation
Experts discuss the multifaceted management of atrial fibrillation, stressing the importance of addressing comorbid conditions alongside the arrhythmia itself, while highlighting the challenges of underdiagnosis, the rise of subclinical cases detected through wearable technology, and the need to align emerging diagnostic tools with evidence-based care to avoid unnecessary interventions and optimize outcomes.
Long-Term Consequences of Arrhythmias
Experts discuss the complex clinical and economic challenges of atrial fibrillation, emphasizing the need for personalized care that balances symptom management, stroke prevention, and risk factor control—while recent evidence on subclinical atrial fibrillation highlights the limitations of widespread anticoagulation, reinforcing the importance of targeted, value-based strategies for optimal outcomes.
Clinical Presentation of Arrhythmias
Experts discuss the growing role of early detection and predictive strategies in managing arrhythmias—particularly atrial fibrillation—highlighting the impact of wearable technology, challenges in diagnosis due to intermittent symptoms, and the shift toward more personalized, value-based care driven by timely evaluation and evidence-based interventions.
The analysis highlighted a shift in heart failure diagnoses, with hypertensive heart disease with and without chronic kidney disease as prevalent diagnoses, underlining coding variability and implications for research.
